| Year |
Citation |
Score |
| 2016 |
Möller T, Bard F, Bhattacharya A, Biber K, Campbell B, Dale E, Eder C, Gan L, Garden GA, Hughes ZA, Pearse DD, Staal RG, Sayed FA, Wes PD, Boddeke HW. Critical data-based re-evaluation of minocycline as a putative specific microglia inhibitor. Glia. PMID 27246804 DOI: 10.1002/glia.23007 |
0.76 |
|
| 2015 |
Sankaranarayanan S, Barten DM, Vana L, Devidze N, Yang L, Cadelina G, Hoque N, DeCarr L, Keenan S, Lin A, Cao Y, Snyder B, Zhang B, Nitla M, Hirschfeld G, ... ... Wes P, et al. Passive immunization with phospho-tau antibodies reduces tau pathology and functional deficits in two distinct mouse tauopathy models. Plos One. 10: e0125614. PMID 25933020 DOI: 10.1371/journal.pone.0125614 |
0.76 |
|
| 2015 |
Wes PD, Holtman IR, Boddeke EWGM, Möller T, Eggen BJL. Next generation transcriptomics and genomics elucidate biological complexity of microglia in health and disease Glia. DOI: 10.1002/glia.22866 |
0.76 |
|
| 2014 |
Wes PD, Easton A, Corradi J, Barten DM, Devidze N, DeCarr LB, Truong A, He A, Barrezueta NX, Polson C, Bourin C, Flynn ME, Keenan S, Lidge R, Meredith J, et al. Tau overexpression impacts a neuroinflammation gene expression network perturbed in Alzheimer's disease. Plos One. 9: e106050. PMID 25153994 DOI: 10.1371/journal.pone.0106050 |
0.76 |
|
| 2014 |
Möller T, Wes PD, Doller D. Microglial biology in neuroinflammatory disease: Pharmaco-industrial approach to target validation Pathological Potential of Neuroglia: Possible New Targets For Medical Intervention. 187-211. DOI: 10.1007/978-1-4939-0974-2-9 |
0.76 |
|
| 2012 |
Hlavacova N, Wes PD, Ondrejcakova M, Flynn ME, Poundstone PK, Babic S, Murck H, Jezova D. Subchronic treatment with aldosterone induces depression-like behaviours and gene expression changes relevant to major depressive disorder. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 15: 247-65. PMID 21375792 DOI: 10.1017/S1461145711000368 |
0.76 |
|
| 2011 |
Kitazawa M, Cheng D, Tsukamoto MR, Koike MA, Wes PD, Vasilevko V, Cribbs DH, LaFerla FM. Blocking IL-1 signaling rescues cognition, attenuates tau pathology, and restores neuronal β-catenin pathway function in an Alzheimer's disease model. Journal of Immunology (Baltimore, Md. : 1950). 187: 6539-49. PMID 22095718 DOI: 10.4049/jimmunol.1100620 |
0.76 |
|
| 2011 |
Cho SH, Sun B, Zhou Y, Kauppinen TM, Halabisky B, Wes P, Ransohoff RM, Gan L. CX3CR1 protein signaling modulates microglial activation and protects against plaque-independent cognitive deficits in a mouse model of Alzheimer disease. The Journal of Biological Chemistry. 286: 32713-22. PMID 21771791 DOI: 10.1074/jbc.M111.254268 |
0.76 |
|
| 2011 |
Barten DM, Cadelina GW, Hoque N, DeCarr LB, Guss VL, Yang L, Sankaranarayanan S, Wes PD, Flynn ME, Meredith JE, Ahlijanian MK, Albright CF. Tau transgenic mice as models for cerebrospinal fluid tau biomarkers. Journal of Alzheimer's Disease : Jad. 24: 127-41. PMID 21422517 DOI: 10.3233/JAD-2011-110161 |
0.76 |
|
| 2008 |
Trinh K, Moore K, Wes PD, Muchowski PJ, Dey J, Andrews L, Pallanck LJ. Induction of the phase II detoxification pathway suppresses neuron loss in Drosophila models of Parkinson's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 465-72. PMID 18184789 DOI: 10.1523/JNEUROSCI.4778-07.2008 |
0.76 |
|
| 2006 |
Whitworth AJ, Wes PD, Pallanck LJ. Drosophila models pioneer a new approach to drug discovery for Parkinson's disease. Drug Discovery Today. 11: 119-26. PMID 16533709 DOI: 10.1016/S1359-6446(05)03693-7 |
0.76 |
|
| 2005 |
Meulener M, Whitworth AJ, Armstrong-Gold CE, Rizzu P, Heutink P, Wes PD, Pallanck LJ, Bonini NM. Drosophila DJ-1 mutants are selectively sensitive to environmental toxins associated with Parkinson's disease. Current Biology : Cb. 15: 1572-7. PMID 16139213 DOI: 10.1016/j.cub.2005.07.064 |
0.76 |
|
| 2005 |
Whitworth AJ, Theodore DA, Greene JC, Benes H, Wes PD, Pallanck LJ. Increased glutathione S-transferase activity rescues dopaminergic neuron loss in a Drosophila model of Parkinson's disease. Proceedings of the National Academy of Sciences of the United States of America. 102: 8024-9. PMID 15911761 DOI: 10.1073/pnas.0501078102 |
0.76 |
|
| 2005 |
Harrison SM, Rudolph JL, Spencer ML, Wes PD, Montell C, Andres DA, Harrison DA. Activated RIC, a small GTPase, genetically interacts with the Ras pathway and calmodulin during Drosophila development. Developmental Dynamics : An Official Publication of the American Association of Anatomists. 232: 817-26. PMID 15712277 DOI: 10.1002/dvdy.20346 |
0.76 |
|
| 2001 |
Wes PD, Bargmann CI. C. elegans odour discrimination requires asymmetric diversity in olfactory neurons. Nature. 410: 698-701. PMID 11287957 DOI: 10.1038/35070581 |
0.76 |
|
| 1999 |
Wes PD, Xu XZ, Li HS, Chien F, Doberstein SK, Montell C. Termination of phototransduction requires binding of the NINAC myosin III and the PDZ protein INAD. Nature Neuroscience. 2: 447-53. PMID 10321249 DOI: 10.1038/8116 |
0.76 |
|
| 1998 |
Xu XZ, Wes PD, Chen H, Li HS, Yu M, Morgan S, Liu Y, Montell C. Retinal targets for calmodulin include proteins implicated in synaptic transmission. The Journal of Biological Chemistry. 273: 31297-307. PMID 9813038 DOI: 10.1074/jbc.273.47.31297 |
0.76 |
|
| 1996 |
Wes PD, Yu M, Montell C. RIC, a calmodulin-binding Ras-like GTPase. The Embo Journal. 15: 5839-48. PMID 8918462 |
0.76 |
|
| 1995 |
Wes PD, Chevesich J, Jeromin A, Rosenberg C, Stetten G, Montell C. TRPC1, a human homolog of a Drosophila store-operated channel. Proceedings of the National Academy of Sciences of the United States of America. 92: 9652-6. PMID 7568191 DOI: 10.1073/pnas.92.21.9652 |
0.76 |
|
| Show low-probability matches. |